Screener Summaries Updates Institutions Sign In More Updates › Financing › BCDA Financing · Jun 8, 2026
BioCardia, Inc. announced in a press release that it sold 3,509,604 shares of common stock at an average price of… BCDA BioCardia, Inc.
BioCardia, Inc. announced in a press release that it sold 3,509,604 shares of common stock at an average price of $1.279 per share on June 5, 2026, pursuant to its "At The Market" offering agreement with H.C. Wainwright & Co.
More from BioCardia, Inc. BioCardia completes PMDA consultation for CardiAMP in Japan, targeting 2028 commercialization Nov 6, 2026 FDA accepts BioCardia's De Novo pre-submission for Helix catheter marketing clearance Oct 19, 2026 BioCardia completes revised Pre-Submission to FDA regarding Helix Catheter approval, expects written feedback within 70 calendar days Oct 1, 2026 BioCardia, Inc. reported financial results for the quarter ended June 30, 2026, announcing a net loss of $1.6 million… Aug 12, 2026 BioCardia, Inc. issued a press release on June 18, 2026, providing a business strategy update and highlighting… Jun 18, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
